Lipoprotein-associated phospholipase A2 and future risk of subclinical disease and cardiovascular events in individuals with type 2 diabetes: The Cardiovascular Health Study

Diabetologia

Volumn 54, Issue 2, 2011, Pages 329-333

  Nelson, T L ^h   Kamineni, A ^a   Psaty, B ^b   Cushman, M ^c   Jenny, N S ^d   Hokanson, J ^e   Furberg, C ^f   Mukamal, K J ^g  

^a GROUP HEALTH RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF VERMONT   (United States)

^e Food Science and Human Nutrition   (United States)

^f WAKE FOREST SCHOOL OF MEDICINE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h NONE

Author keywords

Cardiovascular disease; Cardiovascular Health Study; Diabetes; Lipoprotein associated phospholipase A2; Older adults; Platelet activating factor acetylhydrolase; Subclinical disease; Type 2 diabetes

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; AGED; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 78951484852     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-010-1969-4     Document Type: Article

References (11)

1. 2 in atherosclerosis: biology, epidemiology, and possible therapeutic target Arterioscler Thromb Vasc Biol 25 923 931 1:CAS:528: DC%2BD2MXjsVCjt7Y%3D 10.1161/01.ATV.0000160551.21962.a7 15731492
2. 2) and risk of cardiovascular disease in older adults: results from the Cardiovascular Health Study Atherosclerosis 209 528 532 10.1016/j.atherosclerosis.2009.09.021 19804884
3. 2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study Circulation 111 570 575 1:CAS:528:DC%2BD2MXovFKhuw%3D%3D 10.1161/01.CIR.0000154553.12214.CD 15699277
4. 2 activity and incident coronary heart disease among men and women with type 2 diabetes Diabetes 59 1239 1243 1:CAS:528: DC%2BC3cXmtFegtr0%3D 10.2337/db09-0730 20185811
5. 2) Cardiovasc Drugs Ther 23 73 83 10.1007/s10557-008-6133-8
6. JI Barzilay CF Spiekerman LH Kuller, et al. 2001 Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study Diab Care 24 1233 1239 1:STN:280:DC%2BD3MzovFKlsA%3D%3D 10.2337/diacare.24.7.1233
7. LH Kuller P Velentgas J Barzilay NJ Beauchamp DH O'Leary PJ Savage 2000 Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality Arterioscler Thromb Vasc Biol 20 823 829 1:STN:280:DC%2BD3c7nsl2rtQ%3D%3D 10712409
8. L Fried NO Borhani P Enright, et al. 1991 The Cardiovascular Health Study: design and rationale Ann Epidemiol 1 263 276 1:STN:280: DyaK2c%2FptlOmsA%3D%3D 10.1016/1047-2797(91)90005-W 1669507
9. G Tell LP Fried B Hermanson, et al. 1993 Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study Ann Epidemiol 3 358 366 1:STN:280:DyaK2c7gtFaitw%3D%3D 10.1016/1047-2797(93)90062-9 8275211
10. B Psaty LH Kuller D Bild, et al. 1995 Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study Ann Epidemiol 5 270 277 1:STN:280:DyaK287islWjtg%3D%3D 10.1016/1047-2797(94)00092-8 8520708
11. LH Kuller L Shemanski BM Psaty, et al. 1995 Subclinical disease as an independent risk factor for cardiovascular disease Circulation 92 720 726 1:STN:280:DyaK2MzmvVyjsw%3D%3D 7641349